Evidence map›Paper›PMID 34439592›Full record

ArticleBrain sciences2021

Transcriptomic Data Analysis Reveals a Down-Expression of

Maria Cristina Petralia, Rosella Ciurleo, Alessia Bramanti, Placido Bramanti, Andrea Saraceno, Katia Mangano, Maria Catena Quattropani, Ferdinando Nicoletti, Paolo Fagone

Abstract read
In one paragraph

Article in Brain sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Genetic overlap between treatment-resistant schizophrenia and smoking initiation.The international journal of neuropsychopharmacology · 2026
    Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Maria Cristina PetraliaDepartment of Clinical and Experimental Medicine, University of Messina, 98122 Messina, Italy.
Rosella CiurleoIRCCS Centro Neurolesi "Bonino-Pulejo", 98124 Messina, Italy.
Alessia BramantiDepartment of Medicine, University of Salerno, 84084 Salerno, Italy.
Placido BramantiIRCCS Centro Neurolesi "Bonino-Pulejo", 98124 Messina, Italy.
Andrea SaracenoDepartment of Biomedical and Biotechnological Sciences, University of Catania, 95123 Catania, Italy.
Katia ManganoDepartment of Biomedical and Biotechnological Sciences, University of Catania, 95123 Catania, Italy.ORCID 0000-0001-5920-4620
Maria Catena QuattropaniDepartment of Clinical and Experimental Medicine, University of Messina, 98122 Messina, Italy.
Ferdinando NicolettiDepartment of Biomedical and Biotechnological Sciences, University of Catania, 95123 Catania, Italy.ORCID 0000-0002-4570-8462
Paolo FagoneDepartment of Biomedical and Biotechnological Sciences, University of Catania, 95123 Catania, Italy.ORCID 0000-0002-6694-1992

Funding

IRCCS Centro Neurolesi Bonino-Pulejo Current Research Funds 2021
6 · The paper itself

Abstract

Schizophrenia (SCZ) is a severe psychiatric disorder with several clinical manifestations that include cognitive dysfunction, decline in motivation, and psychosis. Current standards of care treatment with antipsychotic agents are often ineffective in controlling the disease, as only one-third of SCZ patients respond to medications. The mechanisms underlying the pathogenesis of SCZ remain elusive. It is believed that inflammatory processes may play a role as contributing factors to the etiology of SCZ. Galectins are a family of β-galactoside-binding lectins that contribute to the regulation of immune and inflammatory responses, and previous reports have shown their role in the maintenance of central nervous system (CNS) homeostasis and neuroinflammation. In the current study, we evaluated the expression levels of the galectin gene family in post-mortem samples of the hippocampus, associative striatum, and dorsolateral prefrontal cortex from SCZ patients. We found a significant downregulation of

Indexed as

galectinshippocampusLGALS8schizophrenia

Identifiers

PMID34439592
PMCPMC8392448

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.